6 June 2017, New Delhi: On 25 May, an expert committee of the Central Drugs Standard Control Organization (CDSCO), the Indian drug regulatory authority, finally permitted the child-friendly and heat-stable pellet formulation of the HIV drug lopinavir/ritonavir (LPV/r) to be registered. This has opened up crucial supplies from Cipla to the Indian National AIDS Control … Read more
New Delhi/Geneva : MSF response on the India-EFTA free trade agreement negotiations in Liechtenstein this week Background: On 30 May 2017 (Tuesday), trade talks will resume for the India-EFTA (European Free Trade Association) free trade agreement (FTA) in Liechtenstein, between India and the EFTA countries of Switzerland, Norway, Iceland and Liechtenstein. Through this deal, Swiss … Read more
New Delhi, 8 May 2017 – The Philippines is set to host the 18th round of the Regional Comprehensive Economic Partnership (RCEP) trade agreement’s negotiations in Manila this week. Negotiators from the ten members of the Association of Southeast Asian Nations (ASEAN) and six further countries – India, China, Japan, Australia, New Zealand and South … Read more
At Pfizer’s annual general meeting, MSF brings voice of investors calling on corporation to lower pneumonia vaccine price New York, 27 April 2017 – Today, the international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) is bringing individual investors’ voices to Pfizer’s annual general meeting in New Jersey to hold the pharmaceutical corporation accountable … Read more
New Delhi (India), 27 January 2017 – In a letter to the Ministry of Health, drug-resistant TB (DR-TB) survivors, networks of people living with HIV and public health organisations have called on the Government of India to incorporate the life-saving anti-TB drug delamanid into its Revised National Tuberculosis Control Programme (TB Programme). The letter states that … Read more
Intellectual Property Chapter and the Impact on Access to Medicines This briefing note details Doctors Without Borders / Médecins Sans Frontières (MSF)’s analysis of the Regional Comprehensive Economic Partnership (RCEP) intellectual property chapter draft negotiating text. It highlights in particular the numerous provisions within this chapter that have implications for access to medicines and makes recommendations … Read more
The Regional Comprehensive Economic Partnership (RCEP) trade agreement is being negotiated in secret, without input from public health stakeholders. A leaked draft of the negotiating text has revealed some proposed provisions that could undermine access to price-lowering, generic medicines, and thus, life-saving treatment to millions of people in the developing world. As a medical humanitarian … Read more
Pfizer and GlaxoSmithKline (GSK) should extend their price reduction to all developing countries. New York, 14 November 2016 – The international medical humanitarian organisation Doctors Without Borders/ Médecins Sans Frontières (MSF) welcomes Pfizer’s decision to lower the price of its pneumococcal conjugate vaccine (PCV) for children caught in humanitarian emergencies. For seven years, MSF urged Pfizer and … Read more
The reality of pneumonia can be a very scary and dangerous. Each year, it takes the lives of nearly one million kids. There’s a vaccine to prevent it, but it’s too expensive for many countries to afford. That’s why we need Pfizer and GSK to drop the price to $5/child for all developing countries and … Read more
Access to the new tuberculosis (TB) drugs remains severely limited worldwide, but MSF hopes its experience can inform and encourage wider use, while needed clinical research continues Liverpool, 26 October 2016 – At the annual Union World Conference on Lung Health which starts in Liverpool today, Doctors Without Borders / Médecins Sans Frontières (MSF) will share its experience using … Read more